Bio€quity Presentation 2026

Thank you to the team at Bio€quity Europe 2026 for a great event.

It was a pleasure to see such strong engagement during Jan Thirkettle’s presentation and to connect with so many people across the biotech and investment community.

These conversations are an important part of driving step-change innovation in Neurodegeneration– we’re excited about what’s ahead.

hashtag#Bioequity hashtag#Biotech hashtag#LifeSciences hashtag#Innovation hashtag#Healthcare hashtag#Networking

Our programmes

Huntington's Disease

ALS and Alzheimer's

Our news

February 2026

Harness Therapeutics Nominates HRN001, a First-in-Class Drug Candidate for Huntington’s Disease and Establishes Clinical Advisory Board

Read more

October 2025

Harness Therapeutics Announces Launch of MISBA® Duo Platform and Research Collaboration with Ono Venture Investment

Read more

June 2025

Harness Therapeutics Publishes HTT CAG Repeat Sizing Methodology Code on GitHub

Read more

February 2025

Harness Therapeutics to Present Nanopore Sequencing Data for Detecting CAG Expansion in the Huntingtin Gene at CHDI Huntington’s Disease Therapeutics Conference

Read more